"By studying Ro's real-world, de-identified data we can generate insights that help us build tools that empower patients to overcome barriers to care and get more personalized support, laying the groundwork for broader access as innovators like Amgen bring the next generation of medicines to people living with obesity and related conditions." As GLP-1s help to transform the obesity treatment landscape, insurance coverage for the medications has remained a key hurdle for patients and providers
In a clinical trial, the safety and effectiveness of ipamorelin were assessed in patients with postoperative ileus
Hot flashes are not listed as a recognized adverse effect in the FDA-approved prescribing information for tirzepatide, and there is no established pharmacological mechanism directly linking tirzepatide to vasomotor symptoms
Every material in contact with the drug - such as elastomeric closures, syringe barrels, and needle shields - requires carefully selected materials and surface treatments to minimize protein adsorption and preserve drug stability throughout its intended shelf life
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial